ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Kun Fan
Matched on ORCID iD 0000-0003-3041-467X; OpenAlex author ID A5103269167. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2018: 3 papers · 2019: 3 papers · 2020: 1 paper
Papers 7
- HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. First author DOI 10.1093/abbs/gmz169↗
- Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cance… Co-author DOI 10.1002/cam4.2463↗
- Kras G12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancer. First author DOI 10.1016/j.canlet.2019.01.013↗
- The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer. First author DOI 10.2147/cmar.s211363↗
- Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00262-018-2235-8↗
- MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2018.01.017↗
- Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions. Co-author DOI 10.1186/s13045-017-0551-7↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhiyao Fan · 7 shared papers, 2018–2020 · strength 0.60
- Paper HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. DOI 10.1093/abbs/gmz169↗
- Paper Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis in… DOI 10.1002/cam4.2463↗
- Paper Kras G12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic … DOI 10.1016/j.canlet.2019.01.013↗
- Xianjun Yu · 7 shared papers, 2018–2020 · strength 0.60
- Paper HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. DOI 10.1093/abbs/gmz169↗
- Paper Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis in… DOI 10.1002/cam4.2463↗
- Paper Kras G12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic … DOI 10.1016/j.canlet.2019.01.013↗
- Chen Liu · 7 shared papers, 2018–2020 · strength 0.60
- Paper HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. DOI 10.1093/abbs/gmz169↗
- Paper Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis in… DOI 10.1002/cam4.2463↗
- Paper Kras G12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic … DOI 10.1016/j.canlet.2019.01.013↗
- Guopei Luo · 7 shared papers, 2018–2020 · strength 0.60
- Paper HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. DOI 10.1093/abbs/gmz169↗
- Paper Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis in… DOI 10.1002/cam4.2463↗
- Paper Kras G12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic … DOI 10.1016/j.canlet.2019.01.013↗
- Kaizhou Jin · 7 shared papers, 2018–2020 · strength 0.60
- Paper HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. DOI 10.1093/abbs/gmz169↗
- Paper Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis in… DOI 10.1002/cam4.2463↗
- Paper Kras G12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic … DOI 10.1016/j.canlet.2019.01.013↗
- Chao Yang · 6 shared papers, 2018–2020 · strength 0.50
- Paper HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. DOI 10.1093/abbs/gmz169↗
- Paper Kras G12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic … DOI 10.1016/j.canlet.2019.01.013↗
- Paper The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreati… DOI 10.2147/cmar.s211363↗
- He Cheng · 4 shared papers, 2018–2019 · strength 0.33
- Paper Kras G12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic … DOI 10.1016/j.canlet.2019.01.013↗
- Paper The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreati… DOI 10.2147/cmar.s211363↗
- Paper MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic … DOI 10.1016/j.canlet.2018.01.017↗
- Yiyin Zhang · 3 shared papers, 2018 · strength 0.22
- Paper Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pan… DOI 10.1007/s00262-018-2235-8↗
- Paper MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic … DOI 10.1016/j.canlet.2018.01.017↗
- Paper Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions. DOI 10.1186/s13045-017-0551-7↗
- Yitao Gong · 2 shared papers, 2019–2020 · strength 0.19
- Cheng He · 2 shared papers, 2018–2019 · strength 0.17
- Paper Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis in… DOI 10.1002/cam4.2463↗
- Paper Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pan… DOI 10.1007/s00262-018-2235-8↗
- Yunzhen Qian · 1 shared paper, 2020 · strength 0.10
- Jin Xu · 1 shared paper, 2019 · strength 0.09
- Quanxing Ni · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.